Drug
T Bren
T Bren: highest development phase Phase 3, developed by SystImmune Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- SystImmune Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| T-Bren, Dose level 1 NCT07869836 | Phase 3 | Urothelial Cancer |
Latest
No recent events.
Follow T Bren on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.